Insufficient data on use of inhaled corticosteroids to treat COVID-19

EMA

27 May 2021 - EMA’s COVID-19 taskforce is advising health care professionals that there is currently insufficient evidence that inhaled corticosteroids are beneficial for people with COVID-19.

Although the taskforce found no safety risks from studies so far, it could not exclude the possibility of harm from the use of inhaled corticosteroids in patients with COVID-19 who have normal levels of oxygen.

Read EMA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Europe , COVID-19